|N06 - Psychoanaleptics|
This group comprises antidepressants, psychostimulants, nootropics anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.
|N06B - Psychostimulants, Agents Used for Adhd and Nootropics|
Some drugs used in the treatment of narcolepsy are classified here.
Nootropics are classified in N06BX.
Clonidine and guanfacine also used in ADHD are classified in C02AC.
|N06BA - Centrally Acting Sympathomimetics|
Amfetamine is classified in this group, see comment under A08AA - Centrally acting antiobesity products.
Since atomoxetine is approved for use both in children, adolescents and in adults, the DDD is based on the treatment of a 70 kg person. The majority of the users will, however, probably be under 18 years of age.
|N06BA12 - Lisdexamfetamine|
|Dose||Route of administration||Note|
| ||O|| |